TC Medical(SH:600763) Sou Hu Cai Jing·2025-08-23 20:17Core Viewpoint - Tongce Medical (600763) has shown a positive performance in stock price and financial results, indicating potential growth in the medical services sector [1][3]. Stock Performance - As of August 22, 2025, Tongce Medical's stock closed at 46.74 CNY, up 3.5% from the previous week [1]. - The stock reached a high of 47.1 CNY and a low of 45.1 CNY during the week [1]. - The company's total market capitalization is 20.906 billion CNY, ranking 9th in the medical services sector and 894th among all A-shares [1]. Shareholder Changes - As of June 30, 2025, the number of shareholders increased by 4,997 to 88,100, representing a growth of 6.01% [2][6]. - The average number of shares held per shareholder decreased from 5,380 to 5,075 [2]. Financial Performance - For the first half of 2025, Tongce Medical reported a main revenue of 1.448 billion CNY, a year-on-year increase of 2.68% [3]. - The net profit attributable to shareholders was 321 million CNY, up 3.67% year-on-year [3]. - The second quarter of 2025 saw a main revenue of 704 million CNY, a slight increase of 0.24% year-on-year [3]. - The company reported a debt ratio of 27.51% and a gross profit margin of 40.75% [3]. Company Announcements - The 9th meeting of the 10th Supervisory Board was held on August 22, 2025, where four resolutions were passed, including the removal of two supervisors and the transfer of their powers to the Board's Audit Committee [4]. - The meeting also approved the revision of the company's articles of association and the acquisition of 100% equity in Shanghai Cunjing Dental Clinic [4].